Advertisement
Screener

NOMAD POWER SOLUTIONS, INC. (NMAD) Earnings Per Share, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

NOMAD POWER SOLUTIONS, INC. Earnings Per Share, Basic and Diluted

NOMAD POWER SOLUTIONS, INC. (NMAD) reported Earnings Per Share, Basic and Diluted of -$0.50 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-21.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-21

  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.09.
  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.13.
  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.14.
  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.14.
  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.50.
  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.29.
  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.22.
  • NOMAD POWER SOLUTIONS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.04.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 3 month as first filedEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 6 month as first filedEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 9 month as first filedEarnings Per Share, Basic and Diluted 12 monthEarnings Per Share, Basic and Diluted 12 month as first filed
2021-12-31-$0.50
10-K · filed 2022-03-21
2021-09-30-$0.09
10-Q · filed 2021-11-10
-$0.35
10-Q · filed 2021-11-10
2021-06-30-$0.13
10-Q · filed 2021-08-10
-$0.26
10-Q · filed 2021-08-10
2021-03-31-$0.14
10-Q · filed 2021-05-12
2020-12-31-$0.29
10-K · filed 2022-03-21
2020-09-30-$0.14
10-Q · filed 2021-11-10
-$0.02
10-Q · filed 2020-11-10
-$0.21
10-Q · filed 2021-11-10
-$0.04
10-Q · filed 2020-11-10
2020-06-30-$0.03
10-Q · filed 2021-08-10
-$0.01
10-Q · filed 2020-08-10
-$0.07
10-Q · filed 2021-08-10
-$0.01
10-Q · filed 2020-08-10
2020-03-31-$0.03
10-Q · filed 2021-05-12
-$0.01
10-Q · filed 2020-05-11
2019-12-31-$0.22
10-K · filed 2021-03-26
-$0.04
10-K · filed 2020-03-25
2019-09-30-$0.02
10-Q · filed 2020-11-10
-$0.03
10-Q · filed 2020-11-10
2019-06-30-$0.01
10-Q · filed 2020-08-10
-$0.02
10-Q · filed 2020-08-10
2019-03-31-$0.01
10-Q · filed 2020-05-11
2018-12-31-$0.04
10-K · filed 2020-03-25
2018-09-30-$0.02
10-Q · filed 2019-11-08
-$0.03
10-Q · filed 2019-11-08
2018-06-30-$0.01
10-Q · filed 2019-08-06
-$0.01
10-Q · filed 2019-08-06
2018-03-31-$0.01
10-Q · filed 2019-05-09
2017-12-31-$0.03
10-K · filed 2019-03-25
2017-09-30-$0.01
10-Q · filed 2018-11-08
-$0.02
10-Q · filed 2018-11-08
2017-06-30-$0.01
10-Q · filed 2018-08-02
-$0.02
10-Q · filed 2018-08-02
2017-03-31-$0.01
10-Q · filed 2018-04-27
2016-12-31-$0.01
derived: net income ÷ weighted average shares · filed 2018-03-23
-$0.02
derived: net income ÷ weighted average shares · filed 2018-03-23
-$0.04
derived: net income ÷ weighted average shares · filed 2018-03-23
-$0.04
10-K · filed 2018-03-23
2016-09-30-$0.01
10-Q · filed 2017-11-09
-$0.03
derived: net income ÷ weighted average shares · filed 2017-11-09
-$0.03
10-Q · filed 2017-11-09
-$0.05
derived: net income ÷ weighted average shares · filed 2017-11-09
2016-06-30-$0.01
10-Q · filed 2017-08-04
-$0.02
10-Q · filed 2017-08-04
-$0.03
derived: net income ÷ weighted average shares · filed 2017-08-04
-$0.05
derived: net income ÷ weighted average shares · filed 2017-08-04
2016-03-31-$0.01
10-Q · filed 2017-05-10
-$0.02
derived: net income ÷ weighted average shares · filed 2017-05-10
-$0.04
derived: net income ÷ weighted average shares · filed 2017-05-10
-$0.05
derived: net income ÷ weighted average shares · filed 2017-05-10
2015-12-31-$0.01
derived: net income ÷ weighted average shares · filed 2017-03-29
-$0.03
derived: net income ÷ weighted average shares · filed 2017-03-29
-$0.04
derived: net income ÷ weighted average shares · filed 2017-03-29
-$0.06
10-K · filed 2017-03-29
2015-09-30-$0.02
10-Q · filed 2016-11-04
-$0.03
derived: net income ÷ weighted average shares · filed 2016-11-04
-$0.05
10-Q · filed 2016-11-04
2015-06-30-$0.01
10-Q · filed 2016-08-10
-$0.03
10-Q · filed 2016-08-10
2015-03-31-$0.02
10-Q · filed 2016-05-06
2014-12-31-$0.06
10-K · filed 2016-03-28
2014-09-30-$0.01
10-Q · filed 2015-11-10
-$0.05
10-Q · filed 2015-11-10
2014-06-30-$0.02
10-Q · filed 2015-08-07
-$0.04
10-Q · filed 2015-08-07
2014-03-31-$0.02
10-Q · filed 2015-05-13
2013-12-31-$0.03
10-K · filed 2015-03-27
2013-09-30-$0.01
10-Q · filed 2014-11-12
-$0.02
10-Q · filed 2014-11-12
2013-06-30-$0.01
10-Q · filed 2014-08-08
-$0.02
10-Q · filed 2014-08-08
2013-03-31-$0.01
10-Q · filed 2014-05-09
2012-12-31-$0.09
10-K · filed 2014-03-21
2012-09-30-$0.05
10-Q · filed 2013-11-07
-$0.09
10-Q · filed 2013-11-07
2012-06-30-$0.02
10-Q · filed 2013-08-05
-$0.04
10-Q · filed 2013-08-05
2012-03-31-$0.02
10-Q · filed 2013-05-09
2011-12-31-$0.06
10-K · filed 2013-03-15
2011-09-30-$0.02
10-Q · filed 2012-11-13
-$0.04
10-Q · filed 2012-11-13
2011-06-30-$0.01
10-Q · filed 2012-08-10
-$0.02
10-Q · filed 2012-08-10
2011-03-31-$0.01
10-Q · filed 2012-05-10
2010-12-31-$0.03
10-K · filed 2012-03-29
2010-09-30-$0.01
10-Q · filed 2011-11-10
-$0.02
10-Q · filed 2011-11-10
2010-06-30-$0.01
10-Q · filed 2011-08-12
-$0.02
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Xilio Therapeutics, Inc. (XLO)United States$0.052B